Sriram Ryali insider trades

Open-market stock purchases and sales by Sriram Ryali, Chief Financial Officer at Caribou Biosciences, Inc, from SEC Form 4 filings since Apr 22, 2019.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +43%.

Recent trades

DateStockTradeValue
Feb 20, 2026CRBU Caribou Biosciences, IncBought (not open market)—
Feb 20, 2026CRBU Caribou Biosciences, IncBought (not open market)—

Companies traded

  • CRBU Caribou Biosciences, Inc: 1 buy, last Feb 20, 2026
  • CDXS Codexis, Inc: 1 buy, last Jan 1, 2024
  • EIGR Eiger BioPharmaceuticals, Inc: 1 buy, 1 sale, last Mar 14, 2022

Get free alerts when Sriram Ryali files a new trade →